Oric Pharmaceuticals's total assets for Q3 2025 were $431.19M, an increase of 24.31% from the previous quarter. ORIC total liabilities were $24.27M for the fiscal quarter, a 6.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.